Parker-Hannifin SEC Filings

Ross Andrew D, President & Chief Operating Officer of Parker-Hannifin Corporation (PH), reported sales of common stock on 08/08/2025. The Form 4 shows two sales totaling 4,361 shares (4,242 and 119 shares) at reported weighted-average prices of $732.64 and $733.20; footnotes state the individual sale prices ranged from $732.16–$733.14 and $733.17–$733.21 respectively.

The filing also discloses indirect holdings: 404 shares held by the reporting person's sons and 3,764.02 phantom-share equivalents in the Parker Retirement Savings Plan. The filer adjusted prior reporting to remove 708.37 phantom shares that are cash-settled and payable after separation from service. The Form 4 was filed by one reporting person and includes an explicit offer to provide detailed per-transaction price information on request.

Parker-Hannifin Corporation (PH) submitted a Form 144 notice proposing the sale of 1,103 shares of common stock through broker Kestra (address provided) with an aggregate market value of $810,000. The proposed sale is listed for 08/12/2025 on the NYSE. The shares were acquired as a stock award on 08/11/2024 with payment characterized as compensation. The filer reports no sales in the past three months and makes the standard representation that they are unaware of undisclosed material adverse information about the issuer. Several identifying filer and issuer fields in the provided text are not populated in the content.

Parker-Hannifin filed a Form 144 reporting a proposed sale of 575 shares of common stock through UBS Financial Services, with an approximate aggregate market value of $421,511. The shares were acquired on 04/24/2025 as a restricted stock unit (RSU) vest and the proposed sale date listed is 08/08/2025. The filing shows 127,778,004 shares outstanding, so the block offered represents a very small portion of the company’s total equity. The filer also indicates no securities sold during the past three months and includes the customary Form 144 representation about lack of undisclosed material information.

Parker-Hannifin Form 144 notifies a proposed sale of 360 shares of common stock, with an aggregate market value of $261,000. The shares are to be sold on the NYSE through UBS Financial Services with an approximate sale date of 08/08/2025. The filing shows the shares were acquired on 08/08/2025 by a SAR exercise from Parker Hannifin and that payment was made by wire.

The form states there were no securities sold in the past three months for the account and includes the standard seller representation that they do not possess undisclosed material adverse information. Several administrative identification fields in the provided content (for example, filer CIK and person name) are blank in the excerpt supplied.

Parker-Hannifin Corporation submitted a Form 144 reporting a proposed sale of 588 shares of common stock through UBS on the NYSE, with an aggregate market value of $429,342 and 127,778,004 shares outstanding. The securities were acquired via a SAR exercise and paid by wire on 08/08/2025, and the filer reports no other sales in the past three months.

This notice is a routine insider sale disclosure of a single, small transaction. The quantity reported is a very small portion of the company’s outstanding stock, and the filing primarily serves to document the planned sale and the method of acquisition and payment.

Parker-Hannifin Corporation (PH) submitted a Rule 144 notice for a proposed sale of 2,257 common shares that were acquired as a stock award from the issuer on 04/24/2025. The form lists the intended broker as Kestra and an approximate sale date of 08/08/2025; the aggregate market value is stated as $1,660,000 and the number of shares outstanding is shown as 128,410,000. The nature of payment is identified as compensation.

The filing indicates no securities sold in the past three months. Several filer and contact fields in the provided text (including the filer CIK and the name of the person for whose account the securities are to be sold) are not populated in the content provided, so those identifying and contact details are not available here.

What happened: A Form 144 was filed relating to Parker‑Hannifin (PH) reporting a proposed sale of 278 common shares with an aggregate market value of $204,000.

Why it matters: The shares were acquired as a stock award on 08/26/2022 and the planned sale date is 08/08/2025 on the NYSE. The filer reports no sales in the past three months and certifies they do not have undisclosed material information. This filing is a routine insider sale notice and provides transparency about an intended sale of a small number of shares.

Form: 144 notice filed for Parker-Hannifin Corporation (PH) proposing sale of 1,133 common shares with an aggregate market value of $801,000.00.

Acquisition details: Shares were acquired on 04/24/2025 as a stock award from the issuer and payment is listed as compensation. The filing names broker Kestra (5707 Southwest Pkwy, Bldg 2, STE 400, Austin, TX 78735) and lists the intended exchange as NYSE.

Sale timing and history: Approximate date of sale is 08/08/2025. The filer reports no securities sold in the past 3 months for the account.

Filing: Parker-Hannifin Corporation (PH) Form 144 (LIVE) reporting a proposed sale under Rule 144.

Transaction details: 2,257 common shares to be sold through broker Kestra (address shown) on 08/08/2025 on the NYSE. Aggregate market value reported as $1,660,023.00 and shares outstanding listed as 128,410,000. The securities were acquired as a stock award on 04/24/2025; payment/consideration listed as compensation.

Other: The filer reports Nothing to Report for securities sold in the past three months. Remarks include the attestation about absence of undisclosed material adverse information and a signature notice.